Evidence map›Paper›PMID 27692039›Full record

ArticleThe Journal of general virology2016

Proposed update to the taxonomy of the genera Hepacivirus and Pegivirus within the Flaviviridae family.

Donald B Smith, Paul Becher, Jens Bukh, Ernest A Gould, Gregor Meyers, Thomas Monath, A Scott Muerhoff, Alexander Pletnev, Rebecca Rico-Hesse, Jack T Stapleton and 1 more

Abstract read
In one paragraph

Article in The Journal of general virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. A novel genotype ofFrontiers in cellular and infection microbiology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. The Blood Virome: A new frontier in biomedical science.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024
    Review
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Donald B SmithCentre for Immunity, Infection and Evolution, University of Edinburgh, Scotland, UK.
Paul BecherInstitute of Virology, University of Veterinary Medicine, Hannover, Germany.
Jens BukhCopenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases and Clinical Research Centre, Copenhagen University Hospital, Hvidovre, Denmark.
Ernest A GouldEHESP French School of Public Health, French Institute of Research for Development (IRD), Aix Marseille Université, EPV UMR_D 190 Emergence des Pathologies Virales, Marseille, France.
Gregor MeyersInstitut für Immunologie, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany.
Thomas MonathHookipa Biotech AG, Vienna, Austria.
A Scott MuerhoffAbbott Diagnostics Research and Development, Abbott Park, IL, USA.
Alexander PletnevLaboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Rebecca Rico-HesseDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
Jack T StapletonMedical Service, Iowa City Veterans Affairs Medical Center, Iowa City, IA, USA.
Peter SimmondsCentre for Immunity, Infection and Evolution, University of Edinburgh, Scotland, UK.

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Christopher K Laubenthal · 2000 to 2026
$70.0M
Development Of New Approaches To Vaccines Against TBEV and West Nile VirusZIAAI000637 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI PLETNEV, ALEXANDER · 2009 to 2022
$19.1M
Therapy of Dengue with Modified Antibodies in Humanized MiceR01AI098715 · NIAID · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI RICO-HESSE, REBECCA R · 2012 to 2015
$2.9M
Mosquito Saliva in Dengue Virus PathogenesisR01AI099483 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI RICO-HESSE, REBECCA R · 2013 to 2017
$2.6M
NIAID NIH HHS R01 AI098715NIAID NIH HHS R01 AI099483Wellcome Trust
6 · The paper itself

Abstract

Proposals are described for the assignment of recently reported viruses, infecting rodents, bats and other mammalian species, to new species within the Hepacivirus and Pegivirus genera (family Flaviviridae). Assignments into 14 Hepacivirus species (Hepacivirus A-N) and 11 Pegivirus species (Pegivirus A-K) are based on phylogenetic relationships and sequence distances between conserved regions extracted from complete coding sequences for members of each proposed taxon. We propose that the species Hepatitis C virus is renamed Hepacivirus C in order to acknowledge its unique historical position and so as to minimize confusion. Despite the newly documented genetic diversity of hepaciviruses and pegiviruses, members of these genera remain phylogenetically distinct, and differ in hepatotropism and the possession of a basic core protein; pegiviruses in general lack these features. However, other characteristics that were originally used to support their division into separate genera are no longer definitive; there is overlap between the two genera in the type of internal ribosomal entry site and the presence of miR-122 sites in the 5' UTR, the predicted number of N-linked glycosylation sites in the envelope E1 and E2 proteins, the presence of poly U tracts in the 3' UTR and the propensity of viruses to establish a persistent infection. While all classified hepaciviruses and pegiviruses have mammalian hosts, the recent description of a hepaci-/pegi-like virus from a shark and the likely existence of further homologues in other non-mammalian species indicate that further species or genera remain to be defined in the future.

Indexed as

AnimalsChiropteraFlaviviridaeFlaviviridae InfectionsGenetic VariationHepacivirusHepatitis CHumansMammalsPhylogenyRodentiaSequence Analysis, DNA

Identifiers

PMID27692039
PMCPMC5770844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.